Clinical Trials Browser

Interventional × Klatskin Tumor × Magnetic Resonance Spectroscopy × Clear all

NCT06178588 2026-02-24

Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma

Phase 2 Active not recruiting

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

NCT06420349 2025-12-22

NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma

Phase 1 Terminated

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor